progressive supranuclear palsy

(redirected from Supranuclear palsy)

Progressive Supranuclear Palsy

 

Definition

Progressive supranuclear palsy (PSP; also known as Steele-Richardson-Olszewski syndrome) is a rare disease that gradually destroys nerve cells in the parts of the brain that control eye movements, breathing, and muscle coordination. The loss of nerve cells causes palsy, or paralysis, that slowly gets worse as the disease progresses. The palsy affects ability to move the eyes, relax the muscles, and control balance.

Description

Progressive supranuclear palsy is a disease of middle age. Symptoms usually begin in the 60s, rarely before age 45 or after age 75. Men develop PSP more often than women do. It affects three to four people per million each year.

Causes and symptoms

PSP affects the brainstem, the basal ganglia, and the cerebellum. The brainstem is located at the top of the spinal cord. It controls the most basic functions needed for survival-the involuntary (unwilled) movements such as breathing, blood pressure, and heart rate. The brainstem has three parts: the medulla oblongata, the pons, and the midbrain. The parts affected by PSP are the pons, which controls facial nerves and the muscles that turn the eye outward, and the midbrain, the visual center. The basal ganglia are islands of nerve cells located deep within the brain. They are involved in the initiation of voluntary (willed) movement and control of emotion. Damage to the basal ganglia causes muscle stiffness (spasticity) and tremors. The cerebellum is located at the base of the skull. It controls balance and muscle coordination.
Vision is controlled by groups of cells called nuclei in the brainstem. In PSP, the nuclei continue to function, but the mechanisms that control the nuclei are destroyed. The term supranuclear means that the damage is done above (supra) the nuclei. Patients with PSP have difficulty with voluntary (willed) eye movement. At first, the difficulty only occurs in trying to look down. As the disease progresses, ability to move the eyes right and left is also affected. However, reflex or unwilled eye movements remain normal. Thus, when the patient's head is tilted upwards, the eyes move to look down. These reflex movements remain normal until late in the course of the disease. The upper eyelids may be pulled back, the eyebrows raised, and the brow wrinkled, causing a typical wide-eyed stare. Rate of blinking may decrease from the normal 20-30 per minute to three to five per minute. It becomes difficult to walk downstairs, to maintain eye contact during conversation, or to move the eyes up and down to read.
The earliest symptoms of PSP may be frequent falls or stiff, slow movements of the arms and legs. These symptoms may appear as much as five years before the characteristic vision problems. Walking becomes increasingly awkward, and some patients tend to lean and fall backward. Facial muscles may be weak, causing slurred speech and difficulty swallowing. Sleep may be disturbed and thought processes slowed. Although memory remains intact, the slowed speech and thought patterns and the rigid facial expression may be mistaken for senile dementia or Alzheimer's disease. Emotional responses may become exaggerated and inappropriate, and the patient may experience anxiety, depression, and agitation.
The cause of PSP is not known. Most people who develop PSP come from families with no history of the disease, so it does not seem to be inherited, except in certain rare instances. People who have PSP seem to lack the neurotransmitters dopamine and homovanillic acid in the basal ganglia. Neurotransmitters are chemicals that help carry electrical impulses along the nervous system. Transmitting structures in brain cells called neurofibrils become disorganized (neurofibrillary tangles). Neurofibrillary tangles are also found in Alzheimer's disease, but the pattern is somewhat different.

Diagnosis

PSP is sometimes mistaken for Parkinson's disease, which is also associated with stiffness, frequent falls, slurred speech, difficulty swallowing, and decreased spontaneous movement. The facial expression in Parkinson's, however, is blank or mask-like, whereas in PSP it is a grimace and wide-eyed stare. PSP does not cause the uncontrolled shaking (tremor) in muscles at rest that is associated with Parkinson's disease. Posture is stooped in Parkinson's disease, but erect in PSP. Speech is of low volume in both diseases, but is more slurred and irregular in rhythm in PSP.
Multiple strokes or abnormal accumulations of fluid within the skull (hydrocephalus) can also cause balance problems similar to PSP. Magnetic resonance imaging (MRI) scans of the brain may be needed to rule out these conditions. In advanced cases, MRI shows characteristic abnormalities in the brainstem described as "mouse ears."

Treatment

PSP cannot be cured. Drugs are sometimes given to relieve symptoms, but drug treatment is usually disappointing. Dopaminergic medications used in Parkinson's disease, such as levodopa (Sinemet), sometimes decrease stiffness and ease spontaneous movement. Anticholinergic medications, such as trihexyphenidyl (Artane), which restore function to neurotransmitters, or tricyclic drugs, such as amitriptyline (Elavil) may improve speech, walking, and inappropriate emotional responses.
Speech therapy may help manage the swallowing and speech difficulty in PSP. As the disease progresses, the difficulty in swallowing may cause the patient to choke and get small amounts of food in the lungs. This condition can cause aspiration pneumonia. The patient may also lose too much weight. In these cases, a feeding tube may be needed. The home environment should be modified to decrease potential injury from falls. Walkers can be weighted in front, to prevent backward falls and handrails can be installed in the bathroom. Because the patient cannot look down, low objects like throw rugs and coffee tables should be removed. Dry eyes from infrequent blinking can be treated with drops or ointments.

Key terms

Basal ganglia — Brain structure at the base of the cerebral hemispheres, involved in controlling movement.
Brainstem — Brain structure closest to the spinal cord, involved in controlling vital functions, movement, sensation, and nerves supplying the head and neck.
Cerebellum — The part of the brain involved in coordination of movement, walking, and balance.
Magnetic resonance imaging (MRI) — An imaging technique that uses a large circular magnet and radio waves to generate signals from atoms in the body. These signals are used to construct images of internal structures.
Parkinson's disease — A slowly progressive disease that destroys nerve cells. Parkinson's is characterized by shaking in resting muscles, a stooping posture, slurred speech, muscular stiffness, and weakness.

Prognosis

The patient's condition gradually deteriorates. After about seven years, balance problems and stiffness make it nearly impossible for the patient to walk. Persons with PSP become more and more immobile and unable to care for themselves. Death is not caused by the PSP itself. It is usually caused by pneumonia related to choking on secretions or by starvation related to swallowing difficulty. It usually occurs within 10 years, but if good general health and nutrition are maintained, the patient may survive longer.

Prevention

PSP cannot be prevented.

Resources

Organizations

American Academy of Neurology. 1080 Montreal Ave., St. Paul, MN 55116. (612) 695-1940. http://www.aan.com.
Society for Progressive Supranuclear Palsy, Inc. Suite #5065 Johns Hopkins Outpatient Center, 601 N. Caroline St., Baltimore, MD 21287. (800) 457-4777. http://www.psp.org.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.

pro·gress·ive su·pra·nu·cle·ar pal·sy

[MIM*601104]
a slowly progressive, ultimately fatal neurologic disorder with onset after the age of 40 years. Initial symptoms include difficulties in balance with repeated falls, ocular motility disturbances, slurred speech, and dysphasia; later findings include axial dystonia, supranuclear ophthalmoplegia, pseudobulbar palsy, and parkinsonism (but without tremor and with a poor response to l-dopa).
Farlex Partner Medical Dictionary © Farlex 2012

progressive supranuclear palsy

An idiopathic condition characterised by progressive degeneration of basal ganglia, oculomotor nuclei, and periaqueductal gray matter, affecting 4–6/105 of the general population and 4-6% of patients with Parkinsonism.
 
Prognosis
Patients eventually become bed bound; death in 5–10 years, often from upper respiratory tract infection.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

progressive supranuclear palsy

Dementia-nuchal dystonia, Steel-Richardson-Olszewski syndrome Neurology An idiopathic condition characterized by progressive degeneration of basal ganglia, oculomotor nuclei, and periaqueductal gray matter Clinical Onset after age 50, akinetic rigid syndrome, mask-like facies, fixed stare–supranuclear gaze palsy, ophthalmoplegia, pseudobulbar palsy–with dysarthria and dysphagia, axial dystonia on extension, nystagmus, unsteady gait, balance, mild dementia, slow movements–bradykinesia, ↑ tendon reflexes Prognosis Eventually bedbound, death in 5–10 yrs, often from URI
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

progressive supranuclear palsy

An uncommon neurodegenerative disorder that starts in middle and late life and is often misdiagnosed as Parkinson's disease. The disease features Parkinsonism, partial paralysis of eye movement, reduced blinking rate and postural insecurity with poor balance and a tendency to fall over. About 15 per cent have a degree of progressive cognitive loss with apathy and emotional lability.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

Steele,

John C., Canadian neurologist, d. 1968.
Steele-Richardson-Olszewski disease - Synonym(s): Steele-Richardson-Olszewski syndrome
Steele-Richardson-Olszewski syndrome - a progressive neurologic disorder characterized by a supranuclear paralysis of vertical gaze, retraction of eyelids, exophoria under cover, dysarthria, and dementia. Synonym(s): progressive supranuclear palsy; Steele-Richardson-Olszewski disease
Medical Eponyms © Farlex 2012
References in periodicals archive ?
High levels of neurofilament light chain protein (NFL) together with low levels of amyloid-beta 1-42 distinguished progressive supranuclear palsy from PD at baseline as well as 1 year later, after patients had been receiving dopaminergic therapy for months.
Her dad, Bob Burke, has battled Progressive Supranuclear Palsy (PSP) - for which there is no cure and the life expectancy is around seven years - since 2011.
They first address specific conditions and basic mechanisms in dementia and cognitive decline, including Alzheimer's disease, amyotrophic lateral sclerosis, corticobasal degeneration, Creutzfeldt-Jakob disease, frontotemporal lobar degeneration, Gaucher disease, Huntington's disease, dementia with Lewy bodies, normal pressure hydrocephalus, Parkinson's disease, Pick's disease, posterior cortical atrophy, progressive supranuclear palsy, cognitive vascular impairment, Wernicke-Korsakoff syndrome, risk factors, malnutrition, the role of diet in chronic inflammation and innate immunity in Alzheimer's, pathophysiological mechanisms and nutrition, and body composition.
(10) have showed that the anteroposterior diameter of the inferior portion of the pons in MSA-C patients is lower when compared to patients in the control group or with progressive supranuclear palsy.
[USPRwire, Mon Sep 07 2015] Global Markets Direct's, 'Progressive Supranuclear Palsy - Pipeline Review, H2 2015', provides an overview of the Progressive Supranuclear Palsy's therapeutic pipeline.
A support group for people with Parkinson's plus (multiple system atrophy, progressive supranuclear palsy or other atypical Parkinson's diseases) and their partners.
Mrs Hall had a terminal condition called supranuclear palsy. Mr Cole, who was suffering from mesothelioma - a type of cancer caused by asbestos - said before he died that he was "taking a stand" against laws which make it illegal for others to encourage or assist someone trying to take their own life.
His wife ended her own life at the age of 67 at the same clinic after being diagnosed with supranuclear palsy, a rare and terminal illness.
Elinor Dunshee Johnson, 86WORCESTER - Elinor Dunshee Johnson, age 86, died on Sunday, March 8, 2015 at the Knollwood Nursing Center after a long battle with Progressive Supranuclear Palsy.She leaves her husband of 66 years, Stanley Murray Johnson, of the Briarwood Retirement Community; her son and daughter-in-law Kenneth & Andrea Johnson of Worcester; her daughter and son-in-law Joanne and John Schmidt of Milford, NH; her grandchildren Emily Finkel and her husband Noah, Gregory Johnson and his wife Stacey, Matthew Schmidt and his fiancee Hannah Gilday, Jonathan Schmidt and his wife Lynse, Kathryn Schmidt; and great grandchildren Madeline and Alden Finkel and Gavin and Trenton Schmidt.
[ClickPress, Mon Dec 08 2014] Global Markets Direct's, 'Progressive Supranuclear Palsy - Pipeline Review, H2 2014', provides an overview of the Progressive Supranuclear Palsy's therapeutic pipeline.
When we heard the painful news that Phyllis Frelich was struck down by a rare and deadly illness, a degenerative brain disease called PSP (progressive supranuclear palsy), those of us who knew her cried, "It is not possible!" Phyllis is too strong, too courageous, too determined to let this happen.
The asset is a preclinical monoclonal antibody which can be used for treatment of tauopathies such as progressive supranuclear palsy (PSP), potentially entering phase 1 clinical trials in PSP by early 2015, the buyer said.